Washington: The White House's Big Pharma Deal

Thursday, September 24, 2009

The Takeaway's Washington correspondent, Todd Zwillich, joins us with a look at a deal the White House reached earler this year with drug companies. The deal stipulated that pharmaceutical companies would cut name-brand drug prices by 50% for seniors who aren't covered under Medicare's drug plan. In exchange, the White House promised no further cuts to the pharmaceutical industry. While both the White House and Sen. Max Baucus (D-Mont.) want to honor the deal, some Democrats are appalled by the seeming kowtowing to special interests.


Todd Zwillich

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.